A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia
Status:
Completed
Trial end date:
2017-04-05
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to investigate whether a single infusion of
intravenous sodium nitroprusside (0.5 μg/kg/min for 4 hours) is superior to placebo (5%
dextrose solution) at in treating positive and negative symptoms of schizophrenia